Literature Cited

  • 1
    Ager S, Scott MA, Mahendra P, Richards EM, Jestice HK, Beraks P, Baglin TP, Marcus RE: Peripheral blood stem cell transplants after high-dose chemotherapy in patients with malignant lymphoma: A retrospective comparison with autologous bone marrow transplantation. Bone Marrow Transplant 16: 7983, 1995.
  • 2
    Armitage S, Hargreaves R, Samson D, Brennan M, Kanfer E, Navarrete C: CD34 counts to predict adequate collection of peripheral blood progenitor cells. Bone Marrow Transplant 20: 587591, 1997.
  • 3
    Barnett D, Granger V, Mayr P, Storie I, Wilson GA, Reilly JT: Evaluation of a novel stable whole blood quality control material for lymphocyte subset analysis: Results from the UK NEQAS Immune Monitoring Scheme. Cytometry 26: 216222, 1996.
  • 4
    Barnett D, Granger V, Storie I, Peel J, Pollitt R, Smart T, Reilly JT: Quality assessment of CD341 stem cell enumeration: Experience of the United Kingdom National External Quality Assessment Scheme (UK NEQAS) using a unique stable whole blood preparation. Br J Haematol, in press.
  • 5
    Bender JG, To LB, Williams S, Schwartzberg LS: Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1: 329341, 1992.
  • 6
    Bender JG, Williams SF, Myers S, Nottleman D, Lee WJ, Unverzagt KL, Walker D, To LB, Van Epps DE: Characterization of chemotherapy mobilized peripheral blood progenitor cells for use in autologous stem cell transplantation. Bone Marrow Transplant 10: 281285, 1992.
  • 7
    Bender JG, Unverzagt K, Walker D: Guidelines for determination of CD341 cells by flow cytometry: Application to the harvesting and transplantation of peripheral blood stem cells. In: Hematopoietic Stem Cells: The Mulhouse Manual, WunderE, SovalatH, HenonPR, SerkeS (eds). AlphaMed Press, Dayton, OH, 1994, pp 3143.
  • 8
    Berardi AC, Wang A, Levine JD, Lopez P, Scadden DT: Functional isolation and characterization of human hematopoietic stem cells. Science 267: 104107, 1995.
  • 9
    Berenson RJ, Andrews RG, Bensinger WI, Kalamasz D, Knitter G, Buckner CD, Bernstein ID: Antigen-CD341-marrow cells engraft lethally irradiated baboons. J Clin Invest 81: 951955, 1988.
  • 10
    Bhatia M, Wang JCY, Kapp U, Bonnet D, Dick JE: Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci USA 94: 53205325, 1997.
  • 11
    Bodger MP: Isolation of hemopoietic progenitor cells from human umbilical cord blood. Exp Hematol 15: 869876, 1989.
  • 12
    Borowitz MJ, Guenther KL, Schultz KE, Stelzer GT: Immunophenotyping of acute leukemia by flow cytometry: Use of CD45 and right angle light scatter to gate on leukemic blasts in three color analysis. Am J Clin Pathol 100: 534540, 1993.
  • 13
    Bossuyt X, Marti GE, Fleisher TA: Comparative analysis of whole blood lysis methods for flow cytometry. Cytometry 30: 124133, 1997.
  • 14
    Brando B, Sommaruga E, Siena S, Di Nicola M, Bregni M, Danova M, Comolli G, Mazzola E, Gallo L, Zabiello E, Salvini P, Gianni AM: A multicenter quality evaluation of absolute CD341 cell counts by two different flow cytometric methods (abstract). Cytometry 23 (Suppl 8): 89, 1996.
  • 15
    Brecher ME, Sims L, Schmitz J, Shea T, Bentley SA: North American multicenter study on flow cytometric enumeration of CD341 hematopoietic stem cells. J Hematother 5: 227236, 1996.
  • 16
    Broxmeyer HE, Douglas GW, Hangoc G, Cooper S, Bard J, English D, Arny M, Thomas L, Boyse EA: Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 86: 38283832, 1989.
  • 17
    Cairo MS, Wagner JE: Placental and/or umbilical cord blood: An alternative source of hematopoietic stem cells for transplantation. Blood 90: 46654678, 1997.
  • 18
    Caldwell CW, Taylor HM: A rapid, no-wash technique for immunophenotypic analysis by flow cytometry. Am J Clin Pathol 86: 600607, 1986.
  • 19
    Chang A, Ma DDF: The influence of flow cytometric gating strategy on the standardization of CD341 cell quantitation: An Australian multicenter study. J Hematother 5: 605616, 1996.
  • 20
    Chen CH, Lin W, Shye S, Kibler R, Grenier K, Recktenwald D, Terstappen LWMM: Automated enumeration of CD341 cells in peripheral blood and bone marrow. J Hematother 3: 313, 1994.
  • 21
    Chin-Yee I, Keeney M, Anderson L, Nayar R, Sutherland DR: Current status of CD341 cell analysis by flow cytometry: The ISHAGE guidelines. Clin Immunol Newslett 17: 2129, 1997.
  • 22
    Chin-Yee I, Anderson L, Keeney M, Sutherland DR, Canadian QASE Study Group. Quality assurance of stem cell enumeration by flow cytometry. Cytometry 30: 296303, 1997.
  • 23
    Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH: Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG1a cell. J Immunol 133: 157163, 1984.
  • 24
    Civin CI, Almeida-Porada G, Lee MJ, Olweus J, Terstappen L, Zanjani E: Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo. Blood 88: 41024109, 1996.
  • 25
    Connelly MC, Knight M, Giorgi JV, Kagan J, Landay AL, Parker JW, Page E, Spino C, Wilkening C, Mercolino TJ: Standardization of absolute CD41 lymphocyte counts across laboratories: An evaluation of the Ortho CytoronAbsolute flow cytometry system on normal donors. Cytometry 22: 200210, 1995.
  • 26
    Dercksen MW, Gerritsen WR, Rodenhuis S, Dirkson MKA, Slaper-Cortenbach ICM, Schaasberg WP, Pinedo HM, Von den Borne AEGK, Van der Schoot CE: Expression of adhesion molecules on CD341 cells: CD341L-selectin1 cells predict a rapid platelet recovery after peripheral blood stem cell transplantation. Blood 85: 33133319, 1995.
  • 27
    Dercksen MW, Rodenhuis S, Dirkson MKA, Schaasberg WP, Baars JW, Van der Wall E, Slaper-Cortenbach ICM, Pinedo HM, Von dem Borne AEGK, Van der Schoot CE, Gerritsen WR: Subsets of CD341 cells and rapid hematopoietic recovery after peripheral-blood stemcell transplantation. J Clin Oncol 13: 19221932, 1995.
  • 28
    Dietz LJ, Dubrow RS, Manian BS, Sizto NL: Volumetric capillary cytometry: A new method for absolute cell enumeration. Cytometry 23: 177186, 1996.
  • 29
    Di Giusto DL, Lee R, Moon J, Moss K, O'Toole T, Voytovich A, Webster D, Mule JJ: Hematopoietic potential of cryopreserved and ex vivo manipulated umbilical cord blood progenitor cells evaluated in vitro and in vivo. Blood 87: 12611271, 1996.
  • 30
    Dreger P, Marquardt P, Haferlach T, Jacobs S, Mülverstedt T, Eckstein V, Suttorp M, Löffler H, Müller-Ruchholtz W, Schmitz N: Effective mobilisation of peripheral blood progenitor cells with dexa-BEAM and G-CSF: Timing of harvesting and composition of the leukapheresis product. Br J Cancer 68: 950957, 1993.
  • 31
    Dworzak MN, Fritsch G, Buchinger P, Fleischer C, Printz D, Zellner A, Schöllhammer A, Steiner G, Ambros PF, Gadner H: Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral blood. Blood 83: 415425, 1994.
  • 32
    Echaniz P, De Juan MD, Cuadrado E: DNA staining associated with apoptosis and necrosis in blood lymphocytes of individuals with HIV infection. Cytometry 19: 164170, 1995.
  • 33
    Farley TJ, Rooney W, Kuhns E, Ahmed T, Preti RA: An intralaboratory quality control program for quantitation of CD341 cells by flow cytometry. J Hematother 6: 303308, 1997.
  • 34
    Fritsch G, Buchinger P, Printz D: Use of flow cytometric CD34 analysis to quantify hematopoietic progenitor cells. Leuk Lymphoma 10: 443451, 1993.
  • 35
    Fritsch G, Printz D, Stimpfl M, Dworzak MN, Witt V, Pötschger U, Buchinger P: Quantification of CD341 cells: Comparison of methods. Transfusion 37: 775784, 1997.
  • 36
    Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R, Ortega J, Souillet G, Ferreira E, Laporte JP, Fernandez M, Chastang C for the Eurocord Transplant Group and the European Blood and Marrow Transplantation Group: Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med 337: 373381, 1997.
  • 37
    Goodell MA, Rosenzweig M, Kim H, Marks DF, DeMaria MA, Paradis G, Grupp SA, Sieff CA, Mulligan RC, Johnson RP: Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nature Med 3: 13371345, 1997.
  • 38
    Gratama JW, Kraan J, Levering W, Van Bockstaele DR, Rijkers GT, Van der Schoot CE: Analysis of variation in results of CD341 hematopoietic progenitor cell enumeration in a multicenter study. Cytometry 30: 109117, 1997.
  • 39
    Gratama JW, Van der Linden R, Van der Holt B, Bolhuis RLH, Van de Winkel JGJ: Analysis of factors contributing to the formation of mononuclear cell aggregates ('escapees') in flow cytometric immunophenotyping. Cytometry 29: 250260, 1997.
  • 40
    Gross HJ, Verwer BJH, Houck D, Recktenwald DJ: Detection of rare cells at a frequency of one per million by flow cytometry. Cytometry 14: 519526, 1993.
  • 41
    Gutensohn K, Serke S, Cassens U, Fischer J, Fritsch G, Fruehauf S, Garritsen HSP, Gebauer W, Haas R, Höffkes HG, Humpe A, Kleine HD, Moog R, Riggert J, Rothe G, Schlenke P, Schmitz G, Tonn T, Wörmann B, Ziegler BL: Durchflubzytometrische Analyse CD34-exprimierender hämatopoetischer Zellen in Blut und Zytafereseprodukten. Infusionsther Transfusionsmed 23 (Suppl 2): 123, 1996.
  • 42
    Haas R, Mohle R, Fruehauf S, Goldschmidt H, Witt B, Flentje M, Wannemacher M, Hunstein W: Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant melanoma. Blood 83: 37873794, 1994.
  • 43
    Haas R, Möhle R, Pforsich M, Fruehauf S, Witt B, Goldschmidt H, Hunstein W: Blood-derived autografts collected during granulocyte colony-stimulating factor-enhanced recovery are enriched with early Thy-1+ hematopoietic progenitor cells. Blood 85: 19361943, 1995.
  • 44
    Hartmann O, Le Corroller AG, Blaise D, Michon J, Philip I, Norol F, Janvier M, Pico JL, Baranzelli MC, Rubie H, Coze C, Pinna A, Méresse V, Benhamou E: Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: Hematologic recovery and costs. A randomized, controlled trial. Ann Intern Med 126: 600607, 1997.
  • 45
    Ho AD, Young D, Maruyama M, Corringham RET, Mason JR, Thompson P, Grenier K, Law P, Terstappen L, Lane T: Pluripotent and lineage-committed CD341 subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both. Exp Hematol 24: 14601468, 1996.
  • 46
    Janssen WE, Farmelo MJ, Lee C, Smilee R, Kronish L, Elfenbein GJ: The CD341 cell fraction in bone marrow and blood is not universally predictive of CFU-GM. Exp Hematol 20: 528530, 1992.
  • 47
    Johnsen HE for the Nordic Myeloma Study Group Laboratories: Report from a Nordic workshop on CD341 cell analysis: Technical recommendations for progenitor cell enumeration in leukapheresis from multiple myeloma patients. J Hematother 4: 2128, 1995.
  • 48
    Johnsen HE, Knudsen LM for the Nordic Stem Cell Laboratory Group: Nordic flow cytometry standards for CD341 cell enumeration in blood and leukapheresis products: Report from the second Nordic workshop. J Hematother 5: 237245, 1996.
  • 49
    Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland DR: Single platform flow cytometric absolute CD341 cell counts based on the ISHAGE guidelines. Cytometry 34: 6170, 1998.
  • 50
    Knudsen LM, Gaarsdal E, Jensen L, Nielsen KJ, Nikolaisen K, Johnsen HE: Improved priming for mobilization and optimal timing for harvest of peripheral blood stem cells. J Hematother 5: 399406, 1996.
  • 51
    Krause D, Fackler MJ, Civin CI, May WS: CD 34: Structure, biology, and clinical utility. Blood 87: 113, 1996.
  • 52
    Kreissig C, Kirsch A, Serke S: Characterization and measurement of CD34-expressing hematopoietic cells. J Hematother 3: 263289, 1994.
  • 53
    Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin EC, Ciocci G, Carrier C, Stevens CE, Rubinstein P: Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 335: 157166, 1996.
  • 54
    Lane TA, Law P, Maniyama M, Young D, Burgess J, Mullen M, Mealiffe M, Terstappen LWMM, Hardwick A, Moubayed M, Oldaham F, Corringham RET, Ho AD: Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: Potential role in allogeneic marrow transplantation. Blood 85: 275282, 1995.
  • 55
    Laughlin MJ, Christiansen NP, Herzig GP, Blumenson L, Bonney D, Stewart CC: CD34 progenitor cell subset analyses in normal human bone marrow and marrow harvested after intermediate-dose chemotherapy. Cytometry 26: 235242, 1996.
  • 56
    Lewis ID, Rawling T, Dyson PG, Haylock DN, Juttner CA, To LB: Standardization of the CFU-GM assay using hematopoietic growth factors. J Hematother 5: 625630, 1996.
  • 57
    Lowdell MW, Bainbridge DR, Participants of the Royal Microscopical Society Clinical Flow Cytometry Group QA Schemes: External quality assurance for CD34 cell enumeration: Results of a preliminary national trial. Bone Marrow Transplant 17: 849853, 1996.
  • 58
    Lumley MA, McDonald DF, Czarnecka HM, Billingham LJ, Milligan DW: Quality assurance of CD341 cell estimation in leucapheresis products. Bone Marrow Transplant 18: 791796, 1996.
  • 59
    Lumley MA, Burgess R, Billingham LJ, McDonald DF, Milligan DW: Colony counting is a major source of variation in CFU-GM results between centres. Br J Haematol 97: 481484, 1997.
  • 60
    Macey MG, McCarthy DA, Van Agthoven A, Newland AC: How should CD341 cells be analysed? A study of three classes of antibody and five leukocyte preparation procedures J Immunol Methods 204: 175188, 1997.
  • 61
    Manion K, Frey T: Apoptosis of cells in aged samples as detected by the ProCOUNT reagent. Cytometry 26: 317322, 1996.
  • 62
    Marti G, Johnsen H, Sutherland R, Serke S: A convergence of methods for a world wide standard for CD341 cell enumeration. J Hematother, in press.
  • 63
    Mehta J, Powles R, Treleaven J, Kulkarni S, Horton C, Singhal S: Number of nucleated cells infused during allogeneic and autologous bone marrow transplantation: An important modifiable factor influencing outcome. Blood 90: 38083810, 1997.
  • 64
    Moore MAS, Williams N, Metcalf D: In vitro colony formation by normal and leukemic human hematopoietic cells: Characterization of the colony forming cells. J Natl Cancer Inst 56: 603628, 1973.
  • 65
    Murray LJ, Bruno E, Yeo EL, Tsukamoto A, Hoffman R, Sutherland DR: CDw109 antibody 8A3 identifies a minor subset of CD341 fetal bone marrow cells that includes multilineage and megakaryocyte progenitor cells as well as hematopoietic stem cells. Blood 84 (Suppl 1): 327a, 1994.
  • 66
    Murray L, Chen B, Galy A, Chen S, Tushinski R, Uchida N, Negrin R, Tricot G, Jagannath S, Vesole D, Barlogie B, Hoffman R, Tsukamoto A: Enrichment of human hematopoietic stem cell activity in the CD34+Thy1+Lin subpopulation from mobilized peripheral blood. Blood 85: 368378, 1995.
  • 67
    Murray LJ, Mandich D, Bruno E, Di Giusto RK, Fu WC, Sutherland DR, Hoffman R, Tsukamoto A: Fetal bone marrow CD341CD411 cells are enriched for multipotent hematopoietic progenitors, but not for pluripotent stem cells. Exp Hematol 24: 236245, 1996.
  • 68
    Owens MA, Loken MR: Peripheral blood stem cell quantitation. In: Flow Cytometric Principles for Clinical Laboratory Practice. Wiley-Liss, New York, 1995, pp 111127.
  • 69
    Pérez-Simón JA, Caballero MD, Corral M, Nieto MJ, Orfao A, Vazquez L, Amigo ML, Berges C, Gonzales M, Del Cañizo C, San Miguel I JF: Minimal number of circulating CD341 cells to assure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation. Transfusion, in press.
  • 70
    Pétriz J: Estudio ibérico de intercalibración en la expresión del antígeno de membrana CD34 mediante citrometría de flujo: Resultados preliminares. Sangre 42 (Suppl 1): 10, 1997.
  • 71
    Porwit-MacDonald A, Ivory K, Wilkinson S, Wheatley K, Wong L, Janossy G: Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia. Leukemia 9: 11911198, 1995.
  • 72
    Rappold I, Ziegler B, Köhler I, Marchetto S, Rosnet O, Birnbaum D, Simmons PJ, Zannettino ACW, Hill B, Neu S, Knapp W, Alitalo R, Alitalo K, Ullrich A, Kanz L, Bühring HJ: Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT 3(CD135) receptor tyrosine kinase. Blood 90: 111125, 1997.
  • 73
    Read EJ, Kunitake ST, Carter CS, Chau Q, Yu MY, Klein HG: Enumeration of CD341 hematopoietic progenitor cells in peripheral blood and leucapheresis products by microvolume fluorimetry: A comparison with flow cytometry. J Hematother 6: 291301, 1997.
  • 74
    Richman CM, Weiner RS, Yankee RA: Increase in circulating stem cells following chemotherapy in man. Blood 47: 10311039, 1976.
  • 75
    Rubinstein P, Dobrila L, Rosenfield RE, Adamson JW, Migliaccio G, Migliaccio AR, Taylor PE, Stevens CE: Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 92: 1011910122, 1995.
  • 76
    Russell N, Gratwohl A, Schmitz N: The place of blood stem cells in allogeneic transplantation. Br J Haematol 93: 747753, 1996.
  • 77
    Schmid I, Krall WJ, Uittenbogaart CH, Braun J, Giorgi JV: Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry 13: 204208, 1992.
  • 78
    Schots R, Van Riet I, Damiaens S, Flament J, Lacor P, Staelens Y, Steenssens L, Van Camp B, De Waele M: The absolute number of circulating CD341 cells predicts the number of hematopoietic stem cells that can be collected by apheresis. Bone Marrow Transplant 17: 509515, 1996.
  • 79
    Schwella N, Siegert W, Beyer J, Rick O, Zingsem J, Eckstein R, Serke S, Huhn D: Autografting with blood progenitor cells: Predictive value of preapheresis blood cell counts on progenitor cell harvest and correlation of the reinfused cell dose with hematopoietic reconstitution. Ann Hematol 71: 227234, 1995.
  • 80
    Serke S, Saüberlich S, Huhn D: Multiparameter flow-cytometrical quantitation of circulating CD341 cells: Correlation to the quantitation of circulating haematopoietic progenitor cells by in vitro colony-assay. Br J Haematol 77: 453459, 1991.
  • 81
    Serke S, Huhn D: Expression of class I, II and III epitopes of the CD34 antigen by normal and leukemic hematopoietic cells. Cytometry 26: 154160, 1996.
  • 82
    Serke S, Watts M, Meldgaard Knudsen L, Kreissig C, Schneider U, Schwella N, Linch D, Johnsen H: In vitro clonogenicity of mobilized peripheral blood CD341 expressing cells: Inverse correlation to both relative and absolute numbers of CD34-expressing cells. Br J Haematol 95: 234240, 1996.
  • 83
    Serke S, Arseniev L, Watts M, Fritsch G, Ingles-Esteve J, Johnsen HE, Linch D, Cancelas JA, Meyer O, Kadar JG, Huhn D, Matcham J: Imprecision of counting CFU-GM colonies and CD34-expressing cells. Bone Marrow Transplant 20: 5761, 1997.
  • 84
    Siena S, Bregni M, Brando B, Ravagnani F, Bonadonna G, Gianni AM: Circulation of CD341 hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: Enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 74: 19051914, 1989.
  • 85
    Siena S, Bregni M, Brando B, Belli N, Ravagnani F, Gandola L, Stern AC, Lansdorp PM, Bonadonna G, Gianni AM: Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77: 400409, 1991.
  • 86
    Siena S, Bregni M, Di Nicola M, Peccatori F, Magni M, Brando B, Ravagnani F, Gianni AM: Milan protocol for clinical CD341 cell estimation in peripheral blood for autografting in patients with cancer. In: Hematopoietic Stem Cells: The Mulhouse Manual, WunderE, SovalatH, HenonPR, SerkeS (eds). AlphaMed Press, Dayton, OH, 1994, pp 2330.
  • 87
    Sierra J, Storer B, Hansen JA, Bjerke JW, Martin PJ, Petersdorf EW, Appelbaum FR, Bryant E, Chauncey TR, Sale G, Sanders JE, Storb R, Sullivan KM, Anasetti C: Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: The effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood 1997; 89: 42264235.
  • 88
    Sims LC, Brecher ME, Gertis K, Jenkins A, Nickischer D, Schmitz JL, Sparks S, Wright P, Bentley SA: Enumeration of CD34-positive stem cells: Evaluation and comparison of three methods. J Hematother 6: 213226, 1997.
  • 89
    Sovalat H, Serke S: Identification of CD34-positive cells by multiparameter flow cytometry. In: Peripheral Blood Stem Cell Autografts, WunderEW, HenonPR (eds). Springer Verlag, Berlin, 1993, pp 107127.
  • 90
    Sovalat H, Wunder E, Tienhaara A, Olofsson T, Fritsch G, Silvestri F, Serke S: Commentary: Prospects for standardization of stem cell determination within Europe. J Hematother 3: 293296, 1993.
  • 91
    Stewart AK, Imrie K, Keating A, Anania S, Nayar R, Sutherland DR: Optimizing the CD34+ Thy-1+ stem cell content of peripheral blood collections. Exp Hematol 23: 16191627, 1995.
  • 92
    Sutherland DR, Keating A: The CD34 antigen: Structure, biology and potential clinical applications. J Hematother 1: 115129, 1992.
  • 93
    Sutherland DR, Marsh JCW, Davidson J, Baker MA, Keating A, Mellors A: Differential sensitivity of CD34 epitopes to cleavage by Pasteurella haemolytica glycoprotease: Implications for purification of CD34-positive progenitor cells. Exp Hematol 20: 590599, 1992.
  • 94
    Sutherland DR, Keating A, Nayar R, Anania S, Stewart AK: Sensitive detection and enumeration of CD341 cells in peripheral blood and cord blood by flow cytometry. Exp Hematol 22: 10031010, 1994.
  • 95
    Sutherland DR, Yeo EL, Stewart AK, Nayar R, Di Giusto R, Zanjani E, Hoffman R, Murray LJ: Identification of CD341 subsets after glycoprotease selection: Engraftment of CD341Thy11Lin- stem cells in fetal sheep. Exp Hematol 24: 795806, 1996.
  • 96
    Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I: QBEnd10 (CD34) antibody is unsuitable for routine use in the ISHAGE CD341 cell determination assay. J Hematother 5: 601603, 1996.
  • 97
    Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I: The ISHAGE guidelines for CD341 cell determination by flow cytometry. J Hematother 5: 213226, 1996.
  • 98
    Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I: Re: Toward a worldwide standard for CD341 enumeration (letter). J Hematother 6: 8589, 1997.
  • 99
    Sutherland HJ, Eaves CJ, Eaves AC, Dragowska W, Lansdorp PM: Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 74: 15631570, 1989.
  • 100
    Terstappen LWMM, Shah VO, Conrad MP, Recktenwald D, Loken MR: Discriminating between damaged and intact cells in fixed flow cytometric samples. Cytometry 9: 477484, 1988.
  • 101
    Terstappen LWMM, Loken MR: Five-dimensional flow cytometry as a new approach for blood and bone marrow differentials. Cytometry 9: 548556, 1988.
  • 102
    Terstappen LWMM, Huang S, Safford M, Lansdorp PM, Loken MR: Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD341CD382 progenitor cells. Blood 77: 12181227, 1991.
  • 103
    Tindle RW, Nichols RA, Chan L, Campana D, Catovsky D, Birnie GD: A novel monoclonal antibody B1-3C5 recognises myeloblasts and non-T, non-B lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow. Leuk Res 9: 19, 1985.
  • 104
    To LB, Haylock DN, Simmons PJ, Juttner CA: The biology and clinical uses of blood stem cells. Blood 89: 22332258, 1997.
  • 105
    Tricot G, Jagannath S, Vesole D, Nelson J, Tindle S, Miller L, Cheson B, Crowley J, Barlogie B: Peripheral blood stem cell transplants for multiple myeloma: Identification of favorable variables for rapid engraftment in 225 patients. Blood 85: 588596, 1995.
  • 106
    Verwer BJH, Ward DM: An automated classification algorithm for ProCOUNT(tm) flow cytometric acquisition and analysis. J Hematother 6: 169, 1997.
  • 107
    Wagner JE, Rosenthal J, Sweetman R, Shu XO, Davies SM, Ramsay NKC, McGlave PB, Sender L, Cairo MS: Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: Analysis of engraftment and acute graft-versus-host disease. Blood 88: 795802, 1996.
  • 108
    Ward T, Grenier K, Knape C, Cadden M, Schmidt J, Verwer B: ProCOUNT(tm): Setting the Standard for Progenitor Cell Enumeration. Becton Dickinson Immunocytometry Systems, San Jose, CA, 1997.
  • 109
    Zimmerman TM, Lee WJ, Bender JG, Mick R, Williams SF: Quantitative CD34 analysis may be used to guide peripheral blood stem cell harvests. Bone Marrow Transplant 15: 439444, 1995.